These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 19687356)

  • 1. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
    Yamada Y; Kinoshita H; Kuwahara K; Nakagawa Y; Kuwabara Y; Minami T; Yamada C; Shibata J; Nakao K; Cho K; Arai Y; Yasuno S; Nishikimi T; Ueshima K; Kamakura S; Nishida M; Kiyonaka S; Mori Y; Kimura T; Kangawa K; Nakao K
    Cardiovasc Res; 2014 Oct; 104(1):183-93. PubMed ID: 25100767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
    Lee TS; Kaku T; Takebayashi S; Uchino T; Miyamoto S; Hadama T; Perez-Reyes E; Ono K
    Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
    Furukawa T; Miura R; Honda M; Kamiya N; Mori Y; Takeshita S; Isshiki T; Nukada T
    Br J Pharmacol; 2004 Dec; 143(8):1050-7. PubMed ID: 15545287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
    Tanaka H; Namekata I; Ogawa T; Tsuneoka Y; Komikado C; Takahara A; Iida-Tanaka N; Izumi-Nakaseko H; Tsuru H; Adachi-Akahane S
    Eur J Pharmacol; 2010 Dec; 649(1-3):263-7. PubMed ID: 20858482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca
    Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
    Morimoto S; Jo F; Maki K; Iwasaka T
    Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.
    Moosmang S; Haider N; Brüderl B; Welling A; Hofmann F
    Circ Res; 2006 Jan; 98(1):105-10. PubMed ID: 16306443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
    Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
    Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
    Ball CJ; Wilson DP; Turner SP; Saint DA; Beltrame JF
    Hypertension; 2009 Apr; 53(4):654-60. PubMed ID: 19237682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective T-type Ca2+ channel blocker R(-) efonidipine.
    Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
    Suzuki S; Ohkusa T; Ono K; Sato T; Yoshida MA; Yano M; Takebayashi S; Matsuzaki M
    Circ J; 2007 Dec; 71(12):1970-6. PubMed ID: 18037756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
    Perez-Reyes E; Van Deusen AL; Vitko I
    J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
    Tanaka T; Tsutamoto T; Sakai H; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2007 Aug; 30(8):691-7. PubMed ID: 17917316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac T-type Ca(2+) channels in the heart.
    Ono K; Iijima T
    J Mol Cell Cardiol; 2010 Jan; 48(1):65-70. PubMed ID: 19729018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts.
    Arh M; Budihna MV
    Pflugers Arch; 2000; 440(5 Suppl):R149-50. PubMed ID: 11005649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.